Clinical Trial Update: Woodsmoke Particulate + Prednisone [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial investigating prednisone in the context of woodsmoke particulate exposure and airway inflammation, with results posted on 2024-05-23…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Airway Inflammation

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Airway Inflammation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-23